These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36622509)

  • 1. Mesenchymal stromal cell senescence in haematological malignancies.
    Plakhova N; Panagopoulos V; Vandyke K; Zannettino ACW; Mrozik KM
    Cancer Metastasis Rev; 2023 Mar; 42(1):277-296. PubMed ID: 36622509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone-marrow niche in MDS and MGUS: implications for AML and MM.
    Ghobrial IM; Detappe A; Anderson KC; Steensma DP
    Nat Rev Clin Oncol; 2018 Apr; 15(4):219-233. PubMed ID: 29311715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts.
    Yang Y; Li J; Geng Y
    J Biochem; 2020 Nov; 168(5):491-498. PubMed ID: 32770182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
    Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
    Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular senescence and hematological malignancies: From pathogenesis to therapeutics.
    Hu D; Yuan S; Zhong J; Liu Z; Wang Y; Liu L; Li J; Wen F; Liu J; Zhang J
    Pharmacol Ther; 2021 Jul; 223():107817. PubMed ID: 33587950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.
    Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M
    Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
    Nadeau S; Cheng A; Colmegna I; Rodier F
    Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells.
    Vanegas NP; Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities.
    Ruiz-Aparicio PF; Vernot JP
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R
    Front Immunol; 2022; 13():1078421. PubMed ID: 36569863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.
    Janel A; Dubois-Galopin F; Bourgne C; Berger J; Tarte K; Boiret-Dupré N; Boisgard S; Verrelle P; Déchelotte P; Tournilhac O; Berger MG
    Stem Cells Dev; 2014 Dec; 23(24):2972-82. PubMed ID: 25055118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.
    Pontikoglou C; Kastrinaki MC; Klaus M; Kalpadakis C; Katonis P; Alpantaki K; Pangalis GA; Papadaki HA
    Stem Cells Dev; 2013 May; 22(9):1329-41. PubMed ID: 23249221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
    Wu L; Amarachintha S; Xu J; Oley F; Du W
    Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
    Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
    Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
    Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicle-mediated cell-cell communication in haematological neoplasms.
    Ohyashiki JH; Umezu T; Ohyashiki K
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.